Press release

Northlane Capital Partners Closes Fund II at $408 Million

Sponsored by Businesswire

Northlane Capital Partners (“Northlane” or “NCP”), a middle market private equity firm targeting investments in healthcare and business services, today announced that it has successfully raised its second independent fund, Northlane Capital Partners II, L.P. (“NCP II” or “Fund II”). NCP II closed on total capital commitments of $408 million, exceeding its target of $375 million, and attracted strong interest from a diverse group of investors, including public pension funds, asset managers, insurance companies, high net worth families, foundations, and former portfolio company executives.

Fund II will continue Northlane’s strategy of targeting niche outsourced service providers in its two industry verticals that we believe demonstrate consistent performance across economic cycles and operate in subsectors poised to benefit from secular growth. The four founding partners have worked together since 2003 and have completed 27 platform investments. Fund II has already invested in two companies – VMG Health, a valuation and transaction advisory firm exclusively focused on the healthcare industry, and Empower Community Care, a global behavioral health organization responsible for distributing evidence-based programs and technologies that seek to transform the lives of troubled youth, their families, and communities. Since NCP II’s initial investment, VMG Health has completed two add-on acquisitions.

About Northlane Capital Partners

Based in Bethesda, MD, NCP is a middle market private equity firm focused on key segments within the healthcare and business services sectors, where its principals have invested more than $1.5 billion of equity capital. NCP’s strategy is to partner with industry leading companies and great management teams, aligning incentives to accelerate growth and build value. NCP was recently named to Inc.’s 2020 Private Equity 50 list of the top founder-friendly private equity firms. For more information, please visit